Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Mildred Pasek"'
Autor:
Natalie R. Goldstein, Philippe Armand, Corey Cutler, Jeng-Shin Lee, Richard C. Mulligan, Di Wu, Vincent T. Ho, Ursula Hainz, Ana Brusic, Robert J. Soiffer, Catherine J. Wu, Anselmo Alonso, Jerome Ritz, Mildred Pasek, John Koreth, Jessica Wong, Joseph H. Antin, Ute E. Burkhardt, Edwin P. Alyea, Jennifer R. Brown, Masayasu Naito, Glenn Dranoff, Ann Perrin, Wanyong Zeng, Sean McDonough, Tetsuro Sasada, Christine Canning, Donna Neuberg, Naa Norkor Hammond, Quinlan L. Sievers, Kristen E. Stevenson
Publikováno v:
Journal of Clinical Investigation. 123:3756-3765
Background Patients with advanced hematologic malignancies remain at risk for relapse following reduced-intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (allo-HSCT). We conducted a prospective clinical trial to test whe
Autor:
Martin C. Mihm, Matthew Vanneman, Vincent T. Ho, Yoon Joong Kang, Robert J. Soiffer, Haesook T. Kim, Joseph H. Antin, Glenn Dranoff, Stefanie Sarantopoulos, Edwin P. Alyea, John Koreth, Jerome Ritz, Corey Cutler, Tetsuro Sasada, Mildred Pasek, Christine Canning, Jeffery L. Kutok
Publikováno v:
Proceedings of the National Academy of Sciences. 106:15825-15830
Through an immune-mediated graft-versus-leukemia effect, allogeneic hematopoietic stem cell transplantation (HSCT) affords durable clinical benefits for many patients with hematologic malignancies. Nonetheless, subjects with high-risk acute myeloid l
Autor:
Ursula Hainz, Catherine J. Wu, Kristen E. Stevenson, Jennifer R. Brown, Glenn Dranoff, Jaewon Choi, N.P. Goldstein, Robert J. Soiffer, John Koreth, P. Armand, Tetsuro Sasada, Corey Cutler, Edwin P. Alyea, Ana Brusic, Jerome Ritz, Christine Canning, Mildred Pasek
Publikováno v:
Biology of Blood and Marrow Transplantation. 16(2)
Autor:
Scott R. Solomon, Robert J. Soiffer, James R. Mason, Asad Bashey, Lawrence E. Morris, Bridget Medina, Edward D. Ball, Linda Vrooman, Ewa Carrier, Mildred Pasek, Sue Corringham, H. Kent Holland, Edwin P. Alyea, Israel Lowy
Relapse of malignancy after allogeneic hematopoietic cell transplantation (allo-HCT) remains a therapeutic challenge. Blockade of the CTLA4 molecule can effectively augment antitumor immunity mediated by autologous effector T cells. We have assessed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26a48f5dccb62efaff59c440d2955382
https://europepmc.org/articles/PMC2644086/
https://europepmc.org/articles/PMC2644086/
Autor:
Lloyd B. Klickstein, Jerome Ritz, Stephanie J. Lee, Carol Reynolds, Edwin P. Alyea, David B. Miklos, Jesse Levin, Robert J. Soiffer, Sook-Bin Woo, Rebecca Macdonell, Joseph H. Antin, Don C. Bienfang, Vincent T. Ho, Haesook T. Kim, Katherine E. Miller, Nathaniel S. Treister, Corey Cutler, Mildred Pasek
Publikováno v:
Blood. 108(2)
B cells may be implicated in the pathophysiology of chronic graft-versus-host disease (GVHD), as evidenced by antibody production against sex-mismatched, Y chromosome–encoded minor HLA antigens in association with chronic GVHD. We therefore designe
Autor:
Joseph H. Antin, Di Wu, Philippe Armand, Jerome Ritz, Natalie R. Goldstein, Mildred Pasek, Corey Cutler, Kristen E. Stevenson, Donna Neuberg, Robert J. Soiffer, Tetsuro Sasada, Vincent T. Ho, Christine Canning, Jennifer R. Brown, Glenn Dranoff, John Koreth, Ute E. Burkhardt, Edwin P. Alyea, Ursula Hainz, Catherine J. Wu
Publikováno v:
Blood. 120:1892-1892
Abstract 1892 Patients with advanced hematological malignancies remain at high risk for eventual disease progression following reduced intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (allo-HSCT). We hypothesized that v
Autor:
Robert J. Soiffer, Haesook T. Kim, Matthew Vanneman, Ritz Jerome, Vincent T. Ho, Edwin P. Alyea, Corey Cutler, John Koreth, Glenn Dranoff, Mildred Pasek, Joseph H. Antin
Publikováno v:
Blood. 112:825-825
Studies have shown that leukemia specific donor immune responses can be elicited by cancer vaccination after allogeneic SCT. Given the likelihood of disease progression in patients with active leukemia at the time of transplant, potential anti-tumor
Autor:
Ewa Carrier, Sue Corringham, Edward D. Ball, Mildred Pasek, Robert J. Soiffer, Linda Vrooman, Scott R. Solomon, James R. Mason, Howard Streicher, Kent Holland, Asad Bashey, Israel Lowy, Lawrence E. Morris, Bridget Medina
Publikováno v:
Blood. 110:1646-1646
Relapse/progression of malignancy (RM) is an important cause of treatment failure and death following allogeneic hematopoietic stem cell transplantation (allo-HCT). CTLA-4 is an important negative regulator of effector T-cell activation. CTLA-4 inhib
Autor:
Asad Bashey, Sue Corringham, Robert J. Soiffer, James R. Mason, Ewa Carrier, Israel Lowy, Mildred Pasek, Edward D. Ball, Bridget Medina, Howard Streicher
Publikováno v:
Blood. 108:410-410
Failure of adoptive cellular immunotherapy is an important cause of relapse of malignancy (RM) and death following allogeneic hematopoietic stem cell transplantation (allo-HCT). CTLA-4 is a negative regulator of activated T-cells. Therapeutic blockad
Autor:
John Koreth, Haesook T. Kim, Edwin P. Alyea, Vincent T. Ho, Robert J. Soiffer, Joseph H. Antin, Glenn Dranoff, Mildred Pasek, Corey Cutler
Publikováno v:
Blood. 108:3680-3680
Disease relapse is a frequent cause of treatment failure in patients undergoing reduced intensity allogeneic stem cell transplantation for advanced MDS and AML. Prior studies with GVAX, a cancer vaccine composed of irradiated autologous myeloblasts m